Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
20
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15–17 July) asks what is driving the obesity pandemic.
Jul 16, 2026
0
14
A major new international study led by Curtin University has found diabetes risk is about more than body weight or obesity, revealing that muscle health also likely plays a major role in whether people develop the condition.
Jul 14, 2026
0
11
Collagen is a protein found in skin, hair, nails, tendons, cartilage and bones. Our bodies naturally produce collagen using the foods we eat. But in recent years, collagen peptides have gained popularity as a supplement to ...
Jul 20, 2026
0
7
A study by researchers at U.S. health insurance and medical services provider Kaiser Permanente, the Food is Medicine Institute at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University, ...
Jul 21, 2026
0
7
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
6
An estimated 1 in 4 adults worldwide has metabolic syndrome. While metabolic syndrome is most often thought of as a warning sign that diabetes or cardiovascular disease may be on the horizon, my team's new study suggests ...
Jul 14, 2026
0
6
A new position statement from the International Osteoporosis Foundation's (IOF) Committee of Scientific Advisors Fracture Working Group urges orthopedic surgeons and bone health specialists to work together to assess and ...
Jul 20, 2026
0
6
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (15–17 July), shows that glucagon-like peptide-1 receptor agonists (GLP-1 ...
Jul 20, 2026
0
5
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
